| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Advanced Nano Technologies Ltd | ASX | $191.35 m | 3.21 AUD | -4.46% |
| Advanced Oncotherapy PLC | LSE | £88.85 m | 29.00 GBX | -1.69% |
| Advanced Oxygen Technologies, Inc. | PINK | $358.93 k | 0.11 USD | -52.61% |
| Advanced Photonix, Inc. | NYSE | $4.49 billion | 45.22 USD | -2.65% |
| Advanced Proteome Therapeutics Corp. | TSX-V | $4.13 m | 0.16 CAD | 14.81% |
| Advanced Share Registry Limited | ASX | $31.38 m | 0.73 AUD | -3.95% |
| Advanced Vision Technology | FRA | 0.00 | 0.00% | |
| Advanced Voice Recognition Systems, Inc. | PINK | $5.55 m | 0.02 USD | 20.00% |
| AdvanSource Biomaterials Corp. | OTCQB | $508.72 k | 0.02 USD | 15.38% |
| Advant-e Corp. | PINK | $26.55 m | 4.45 USD | 0.00% |
| Advantage Lithium Corp. | TSX-V | $43.14 m | 0.27 CAD | -3.64% |
| Advantage Oil & Gas Ltd. | TSX | $338.6 m | 1.80 CAD | -3.74% |
| Advantaged CDN High Yield Bond Fund | TSX | $15.92 m | 7.31 CAD | -0.27% |
| Advantest | NYSE | 0.00 | 0.00% | |
| Advaxis | NASDAQ | $27.88 m | 0.42 USD | 7.40% |
| Advent Software, Inc. | NASDAQ | 0.00 | 0.00% | |
| Adventure Gold Inc | TSX-V | $0.00 | 0.00 CAD | 0.00% |
| ADVENTUS ZINC CORPORATION | TSX-V | $144.2 m | 1.10 CAD | 4.76% |
| Adveritas Ltd | ASX | $40.33 m | 0.13 AUD | 0.00% |
| Adverum Biotechnlogies Inc | NASDAQ | $1.02 billion | 10.45 USD | 1.06% |
| ADVFN | AIM | £4.37 m | 17.00 GBX | 9.68% |
| AdvisorShares ETF | NYSEMKT | $33.99 m | 11.24 USD | 0.98% |
| ADX Energy Limited | ASX | $8.57 m | 0.01 AUD | -16.67% |
| AECOM Technology | NYSE | $6.64 billion | 41.37 USD | 1.12% |
| Aecon Group | TSX | $827.49 m | 13.82 CAD | 0.66% |
| Aeeris Ltd | ASX | $6 m | 0.10 AUD | 0.00% |
| AEGEAN Airlines | PINK | $266.39 m | 3.73 USD | -7.94% |
| Aegle Therapeutics Corp | Unlisted | 0.00 | 0.00% | |
| Aeglea Biotherapeutics | NASDAQ | $315.32 m | 7.07 USD | -1.39% |
| Aehr Test Systems | NASDAQ | $32.87 m | 1.41 USD | -0.70% |
| Aemetis Inc | NASDAQ | $66.48 m | 3.17 USD | 10.26% |
| Aeolus Pharmaceuticals, Inc. | PINK | $295.05 k | 0.00 USD | -15.65% |
| AEON Biopharma | Unlisted | 0.00 | 0.00% | |
| Aeon Metals Ltd | ASX | $74.53 m | 0.11 AUD | -8.33% |
| Aeorema Communications | AIM | £1.89 m | 20.50 GBX | 0.00% |
| AEP Industries | NASDAQ | 0.00 | 0.00% | |
| Aequus Pharmaceuticals Inc. | TSX-V | $14.52 m | 0.13 CAD | 4.00% |
| AER Lingus Group plc | LSE | 0.00 | 0.00% | |
| Aerie Pharmaceuticals | NASDAQ | $531.66 m | 11.43 USD | 3.63% |
| Aeris Environmental Ltd | ASX | $122.49 m | 0.51 AUD | -0.98% |